Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality and artificial intelligence, MindMaze has enhanced the recovery potential of patients with neurological diseases.

Combining FDA cleared and CE marked digital therapeutics with advanced motion analytics, AI and cloud technologies, MindMaze aims to create a universal platform for brain health.

Beyond healthcare, MindMaze Labs is an R&D division focused on bringing neuroscience breakthroughs to everyday life, empowering the next generation of human-machine interfaces.

MindMaze has transformed care for neurological diseases within a decade and plans ambitious growth for the next decade. Their pioneering digital therapies employ immersive, scientifically rigorous experiences for neurorehabilitation.

They hold multiple patents, regulatory approvals, and partnerships with prominent institutions globally. MindMaze's innovative products include MindMotion GO, MindMotion PRO, and MindPod, offering digital therapeutics and assessments for brain health and recovery.

The company emphasizes teleneurorehabilitation, enabling patients worldwide to access therapy from home via their platforms.